𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of Versant HBV DNA 3.0 and COBAS AmpliPrep–COBAS TaqMan assays for hepatitis B DNA quantitation: Possible clinical implications

✍ Scribed by A.R. Garbuglia; C. Angeletti; F.N. Lauria; P. Zaccaro; A.M. Cocca; M. Pisciotta; M. Solmone; M.R. Capobianchi


Book ID
113767623
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
357 KB
Volume
146
Category
Article
ISSN
0166-0934

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Clinical evaluation of the COBAS Amplipr
✍ Fabrizia Pittaluga; Tiziano Allice; Maria Lorena Abate; Alessia Ciancio; Frances 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

## Abstract Diagnosis and monitoring of HCV infection relies on sensitive and accurate HCV RNA detection and quantitation. The performance of the COBAS AmpliPrep™/COBAS TaqMan™ 48 (CAP/CTM) (Roche, Branchburg, NJ), a fully automated, real‐time PCR HCV RNA quantitative test was assessed and compared

Comparison of the COBAS TaqMan™ HBV test
✍ Simon Siu-Man Sum; Danny Ka-Ho Wong; John Chi-Hang Yuen; Ching-Lung Lai; Man-Fun 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Quantitation of low hepatitis B virus (HBV) DNA levels in patients with chronic hepatitis B is important for monitoring natural history of disease and treatment efficacy. This study aimed to compare the quantitation range and analytical sensitivity of the newly developed COBAS TaqMan HBV test (TaqMa